Literature DB >> 27882653

Synkinesis in Bell's palsy in a randomised controlled trial.

N Bylund1, D Jensson2, S Enghag1, T Berg3, E Marsk4, M Hultcrantz4, N Hadziosmanovic5, A Rodriguez-Lorenzo2, L Jonsson1.   

Abstract

OBJECTIVES: To study the development of synkinesis in Bell's palsy. Frequency, severity, gender aspects and predictors were analysed.
DESIGN: Data from the randomised controlled Scandinavian Bell's palsy trial including 829 patients. MAIN OUTCOME MEASURES: Frequency and severity of synkinesis at 12 months were the main outcome measures. Mean Sunnybrook synkinesis scores, voluntary movement scores and composite scores between 6 and 12 months were compared.
RESULTS: In 743 patients with a 12-month follow-up, synkinesis frequency was 21.3%. There was no gender difference. Synkinesis was moderate to severe in 6.6% of patients. Those with synkinesis at 6 months had a synkinesis score of 4.1 (±2.8 sd), which increased to 4.7 (±3.2) (P = 0.047) at 12 months (n = 93). Sunnybrook composite score at 1 month was the best predictor for synkinesis development with receiver operating characteristics and area under the curve (AUC) 0.87. Risk for synkinesis increased with a lower Sunnybrook composite score. Furthermore, at 1 month, symmetry of voluntary movement had higher predictive value for synkinesis than resting symmetry with AUC 0.87 and 0.77, respectively. Gentle eye closure and open-mouth smile were the only independent significant predictive items (AUC 0.86).
CONCLUSIONS: Moderate-to-severe synkinesis was present in 6.6% of patients. The mean synkinesis score increased between 6 and 12 months, and outcome should therefore be evaluated after at least 12 months. Sunnybrook composite score and symmetry of voluntary movement at 1 month were good predictors for synkinesis.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27882653     DOI: 10.1111/coa.12799

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  7 in total

1.  Oro-facial motor assessment: validation of the MBLF protocol in facial palsy.

Authors:  Diane Picard; Elodie Lannadere; Estelle Robin; Rémi Hervochon; Georges Lamas; Frédéric Tankere; Peggy Gatignol
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-27       Impact factor: 2.503

2.  The Diagnosis and Treatment of Idiopathic Facial Paresis (Bell's Palsy).

Authors:  Josef Georg Heckmann; Peter Paul Urban; Susanne Pitz; Orlando Guntinas-Lichius; Ildikό Gágyor
Journal:  Dtsch Arztebl Int       Date:  2019-10-11       Impact factor: 5.594

3.  Using High-Resolution Ultrasound to Assess Post-Facial Paralysis Synkinesis-Machine Settings and Technical Aspects for Facial Surgeons.

Authors:  Andreas Kehrer; Marc Ruewe; Natascha Platz Batista da Silva; Daniel Lonic; Paul Immanuel Heidekrueger; Samuel Knoedler; Ernst Michael Jung; Lukas Prantl; Leonard Knoedler
Journal:  Diagnostics (Basel)       Date:  2022-07-07

4.  Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial.

Authors:  Abbas Ali Pourmomeny; Elham Pourali; Ahamd Chitsaz
Journal:  Iran J Otorhinolaryngol       Date:  2021-05

5.  Acute Peripheral Facial Palsy: Recent Guidelines and a Systematic Review of the Literature.

Authors:  Su Jin Kim; Ho Yun Lee
Journal:  J Korean Med Sci       Date:  2020-08-03       Impact factor: 2.153

6.  A Hybrid Bipolar Active Charge Balancing Technique with Adaptive Electrode Tissue Interface (ETI) Impedance Variations for Facial Paralysis Patients.

Authors:  Ganesh Lakshmana Kumar Moganti; V N Siva Praneeth; Siva Rama Krishna Vanjari
Journal:  Sensors (Basel)       Date:  2022-02-23       Impact factor: 3.576

7.  Surgical Outcomes of Transmastoid Facial Nerve Decompression for Patients With Traumatic Facial Nerve Paralysis.

Authors:  Harun Gür; Kemal Görür; Onur İsmi; Yusuf Vayısoğlu; Kemal Koray Bal; Cengiz Özcan
Journal:  J Int Adv Otol       Date:  2021-07       Impact factor: 1.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.